Tucson, Arizona 85724


This is a feasibility study examining the feasibility and acceptability of a novel psychotherapy intervention on lung cancer patients who are experiencing stigma.

Study summary:

Experiences of stigma (perception and internalization of negative appraisal and devaluation from others) are pervasive for lung cancer patients. Previous work has shown associations between lung cancer stigma and detriments in clinically relevant outcomes such as depression, lower quality of life, and reduced engagement in cancer care. The investigators previously developed Acceptance and Commitment Therapy for Lung Cancer Stigma (ACT-LCS) as a patient-focused intervention to reduce the self-blame, guilt and inhibited disclosure associated with lung cancer stigma. ACT-LCS is based in Acceptance and Commitment Therapy (ACT), a cognitive-behavioral treatment that promotes psychological flexibility through acceptance and valued direction. This is a feasibility study examining the feasibility and acceptability of ACT-LCS.


Inclusion Criteria: - Proficiency in English - Diagnosed with or treated for Non-Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) within the prior 12 months. - Scores of 37.5 on the Lung Cancer Stigma Inventory (LCSI) screening measure Exclusion Criteria: - Not proficient in English



Primary Contact:

Principal Investigator
Heidi Hamann, PhD
University of Arizona

Amy Selegue, BA, BSN, RN
Phone: 520-626-0301
Email: aselegue@email.arizona.edu

Backup Contact:


Location Contact:

Tucson, Arizona 85724
United States

Heidi Hamann, PhD
Phone: 520-621-7447
Email: heidihamann@email.arizona.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.